Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Delirium After OPCABG in Elderly
ChiCTR-IPR-16008415Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in coronary arteriosclerosis (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Postoperative delirium. Started Apr 2016; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-16008415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008415.